Statement of Changes in Beneficial Ownership (4)
October 31 2018 - 4:11PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Grauch Edward Rowland
|
2. Issuer Name
and
Ticker or Trading Symbol
BLONDER TONGUE LABORATORIES INC
[
BDR
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive Vice President & COO
|
(Last)
(First)
(Middle)
C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
10/29/2018
|
(Street)
OLD BRIDGE, NJ 08857
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (right to buy)
|
$0.88
(1)
|
10/29/2018
|
|
A
|
|
150000
|
|
(2)
|
10/29/2028
|
Common Stock par value $0.001
|
150000
|
$0
|
150000
|
D
|
|
Employee Stock Option (right to buy)
|
$0.88
(1)
|
10/29/2018
|
|
A
|
|
350000
|
|
(3)
|
10/29/2028
|
Common Stock par value $0.001
|
350000
|
$0
|
350000
|
D
|
|
Explanation of Responses:
|
(1)
|
The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE American) of the common stock on October 29, 2018.
|
(2)
|
This stock option vests (i) with respect to 30,000 shares on each of October 29, 2019 and 2020 and (ii) with respect to 45,000 shares on each of October 29, 2021 and 2022.
|
(3)
|
This stock option vests (i) with respect to 70,000 shares on each of October 29, 2019 and 2020 and (ii) with respect to 105,000 shares on each of October 29, 2021 and 2022.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Grauch Edward Rowland
C/O BLONDER TONGUE LABORATORIES, INC.
ONE JAKE BROWN ROAD
OLD BRIDGE, NJ 08857
|
|
|
Executive Vice President & COO
|
|
Signatures
|
/s/Edward R. Grauch
|
|
10/31/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Sep 2023 to Sep 2024